Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
5月 13, 2026
2 min read
51

The Trump administration has announced a temporary nationwide halt on Medicare enrollments for new home healthcare and hospice providers. The move, effective Wednesday, is a direct measure by Vice President JD Vance’s anti-fraud task force to address what officials describe as widespread fraud within the system.
This moratorium is part of a broader initiative to combat healthcare scams that cost taxpayers tens of billions of dollars annually. In 2024, Medicare expenditures reached $28.3 billion for hospice care and $16 billion for home healthcare. The administration has raised concerns about the rapid creation of fraudulent businesses and pointed to lax oversight in several states, including California and Minnesota.
The Centers for Medicare & Medicaid Services (CMS) will use this pause to review expenditures and establish more robust oversight guidance.
The decision has drawn mixed reactions from the industry. While some groups support the pause to ensure program integrity, others warn it could inadvertently limit patient access to care. The halt on new entrants may consolidate the market around major existing operators such as BrightSpring Health Services, UnitedHealth, and Chemed Corporation subsidiary VITAS Healthcare. This action follows a similar pause in February for suppliers of durable medical equipment.
The temporary moratorium marks a significant regulatory intervention aimed at protecting the integrity of the Medicare program. The focus now shifts to the new guidelines to be developed by CMS, which will shape the future landscape for home health and hospice care providers across the United States. Stakeholders will be closely monitoring the duration of the pause and the nature of the forthcoming regulations.
Q: Why is the US halting new Medicare enrollments for home health providers?
A: The government has implemented a temporary nationwide moratorium to address widespread fraud concerns and allow federal agencies to develop stronger oversight rules.
Q: How much does Medicare spend on these services?
A: According to the Medicare Payment Advisory Commission, in 2024, Medicare spent $28.3 billion on hospice care and $16 billion on home healthcare services.
Q: Which companies are major players in this sector?
A: Major operators in the home health and hospice market include BrightSpring Health Services, UnitedHealth, and Chemed Corporation's VITAS Healthcare.
Source: [investing.com](https://www.investing.com/news/stock-market-news/exclusiveus-halting-medicare-enrollments-for-new-home-healthcare-and-hospice-providers-4684384)

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles